Yunu CEO Advocates for Enhanced Clinical Trial Imaging to Boost Drug Development
DANA POINT, Calif., March 21, 2024 (VSNewsNetwork.com) - At the LSI Emerging Medtech Summit, Yunu CEO Jeff Sorenson presented the company's cloud platform as a pivotal solution to the prevalent inefficiencies within clinical trial imaging. In his address to an audience of life sciences, biotech, and investment professionals, Sorenson detailed the challenges facing clinical trial imaging and how Yunu's technology is poised to revolutionize the process.
Sorenson pointed out the critical issues undermining the effectiveness of current clinical trial imaging practices, including "workflow inefficiencies, staffing shortages, and outdated systems," which he said contribute to "image assessment error rates of 25% to 50%." These errors, according to Sorenson, lead to significant consequences, such as the enrollment of ineligible patients, protocol violations, and ultimately, the mismanagement of patient treatments. He emphasized, "This constitutes a crisis, as sponsors cannot directly rely on these results to assess outcomes."
Yunu's response to these challenges involves a comprehensive cloud-based ecosystem designed to streamline the imaging workflow in clinical trials. The platform aims to connect all stakeholders, including sponsors, Contract Research Organizations (CROs), imaging CROs, and research sites, facilitating better communication, data sharing, and decision-making processes. Sorenson highlighted the platform's success, noting that Yunu "manages over 4,200 active clinical trials" and has been adopted by leading research institutions.
The CEO underscored the importance of accurate and efficient imaging workflows, stating, "Well-orchestrated imaging workflow that efficiently accomplishes all of the required complex measurements, calculations, tracking, and signoffs is key to creating a future where prospective source data is accurately captured, labeled, and widely available." He also touched on the potential for AI to revolutionize drug development, contingent on the availability of "clean and complete data," including imaging.
For further details on Yunu's approach to improving clinical trial imaging, visit their website at https://www.yunu.io.
Source: Yunu via Newswire
